These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33236576)

  • 1. Vigabatrin Toxicity in a Patient with Infantile Spasms Treated with Concomitant Hormonal Therapy.
    Lotan E; Bluvstein J; Zan E
    Isr Med Assoc J; 2020 Jul; 22(7):461-462. PubMed ID: 33236576
    [No Abstract]   [Full Text] [Related]  

  • 2. Fulminant vigabatrin toxicity during combination therapy with adrenocorticotropic hormone for infantile spasms: Three cases and review of the literature.
    Bhalla S; Skjei K
    Epilepsia; 2020 Oct; 61(10):e159-e164. PubMed ID: 32944947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible vigabatrin-induced life-threatening encephalopathy.
    Hernández Vega Y; Kaliakatsos M; U-King-Im JM; Lascelles K; Lim M
    JAMA Neurol; 2014 Jan; 71(1):108-9. PubMed ID: 24247994
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent.
    Hussain SA; Tsao J; Li M; Schwarz MD; Zhou R; Wu JY; Salamon N; Sankar R
    Epilepsia; 2017 Apr; 58(4):674-682. PubMed ID: 28230253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroids or vigabatrin in the treatment of infantile spasms?
    Riikonen RS
    Pediatr Neurol; 2000 Nov; 23(5):403-8. PubMed ID: 11118795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A risk-benefit assessment of treatments for infantile spasms.
    Nabbout R
    Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigabatrin for infantile spasms.
    Pesaturo KA; Spooner LM; Belliveau P
    Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vigabatrin-induced MRI changes associated with extrapyramidal symptoms in a child with infantile spasms.
    Schonstedt V; Stecher X; Venegas V; Silva C
    Neuroradiol J; 2015 Oct; 28(5):515-8. PubMed ID: 26306928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of West syndrome with vigabatrin: reversible MRI signal changes.
    Carvalho Neto Ad; Coelho LO; Ono SE; Crippa AC
    Arq Neuropsiquiatr; 2011 Dec; 69(6):998. PubMed ID: 22297900
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of vigabatrin in Japanese patients with infantile spasms: Primary short-term study and extension study.
    Ohtsuka Y
    Epilepsy Behav; 2018 Jan; 78():134-141. PubMed ID: 29190579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vigabatrin administration in patients with infantile spasms: the risks.
    Jaseja H
    Clin Neurol Neurosurg; 2010 Nov; 112(9):835. PubMed ID: 20934097
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebral MRI abnormalities associated with vigabatrin therapy.
    Pearl PL; Vezina LG; Saneto RP; McCarter R; Molloy-Wells E; Heffron A; Trzcinski S; McClintock WM; Conry JA; Elling NJ; Goodkin HP; de Menezes MS; Ferri R; Gilles E; Kadom N; Gaillard WD
    Epilepsia; 2009 Feb; 50(2):184-94. PubMed ID: 18783433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are vigabatrin induced T2 hyperintensities in cranial MRI associated with acute encephalopathy and extrapyramidal symptoms?
    Dill P; Datta AN; Weber P; Schneider J
    Eur J Paediatr Neurol; 2013 May; 17(3):311-5. PubMed ID: 23199677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACTH versus vigabatrin therapy in infantile spasms: a retrospective study.
    Cossette P; Riviello JJ; Carmant L
    Neurology; 1999 May; 52(8):1691-4. PubMed ID: 10331702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms.
    Fong CY; Osborne JP; Edwards SW; Hemingway C; Hancock E; Johnson AL; Kennedy CR; Kneen R; Likeman M; Lux AL; Mordekar SR; Murugan V; Newton RW; Pike M; Quinn M; Spinty S; Vassallo G; Verity CM; Whitney A; O'Callaghan FJ
    Dev Med Child Neurol; 2013 Sep; 55(9):862-7. PubMed ID: 23789722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenocorticotropic hormone versus prednisolone in the treatment of infantile spasms post vigabatrin failure.
    Jones K; Snead OC; Boyd J; Go C
    J Child Neurol; 2015 Apr; 30(5):595-600. PubMed ID: 24965788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study.
    Akula JD
    Neurology; 2015 Aug; 85(7):655-6. PubMed ID: 26283761
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of infantile spasms: results of a population-based study with vigabatrin as the first drug for spasms.
    Granström ML; Gaily E; Liukkonen E
    Epilepsia; 1999 Jul; 40(7):950-7. PubMed ID: 10403219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocorticotropic hormone and vigabatrin treatment of children with infantile spasms underlying cerebral palsy.
    Zafeiriou DI; Kontopoulos EE; Tsikoulas IG
    Brain Dev; 1996; 18(6):450-2. PubMed ID: 8980841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ACTH on brain midline structures in infants with infantile spasms.
    Konishi Y; Hayakawa K; Kuriyama M; Saito M; Fujii Y; Sudo M
    Pediatr Neurol; 1995 Sep; 13(2):134-6. PubMed ID: 8534277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.